TCR2 Therapeutics Inc (NASDAQ:TCRR)
| 1.50 Delayed Data As of 4:00pm ET |  +0.06 / +4.17%Today’s Change | 0.82 Today|||52-Week Range 3.88 | +50.18% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | -- | -- |
| Depreciation And Amortization | 220.0K | 298.0K | 419.0K | -- | ||
| Operating Expenses | Gross Income | -220.0K | -298.0K | -419.0K | -- | |
| General Expenses | 9.7M | 12.9M | 26.0M | -- | ||
| Research And Development | 7.7M | 9.6M | 19.3M | -- | ||
| Total Operating Expenses | 9.9M | 13.2M | 26.5M | -- | ||
| Non-Operating Expenses | Operating Income | -9.9M | -13.2M | -26.5M | -- | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -9.9M | -13.1M | -24.3M | -- | |
| Preferred Dividend | -787.0K | -1.8M | -37.3M | -- | ||
| Net Income | -9.9M | -13.1M | -24.3M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 23.9M | 23.9M | 23.9M | -- | |
| Shares To Calculate EPS Diluted | 23.9M | 23.9M | 23.9M | -- | ||
| Earnings Per Share | EPS | -$0.45 | -$0.62 | -$2.57 | -- | |
| EPS Diluted | -$0.45 | -$0.62 | -$2.57 | -- | ||
